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Summary
Proteolytic cleavage of key substrates appears to be an important biochemical mechanism un-
derlying the apoptotic process, and the centrality ofinterleukin 1 [3-converting enzyme (ICE)-
like proteases as mediators of apoptosis has been suggested. The identification of the relevant
substrates of the ICE protease family during apoptosis therefore constitutes a major challenge.
Using human autoantibodies, we demonstrate here that a subset of autoantigens is specifically
cleaved early during apoptosis. One of these cleaved molecules is identified as the catalytic sub-
unit of the DNA-dependent protein kinase . The time courses of all proteolytic cleavages are
identical and coincide with the onset of morphologic apoptosis. Furthermore, all cleavages share
the same inhibition characteristics, which implicate an ICE-like activity(ies). We propose that
cleavage ofthese autoantigens targets these molecules for an autoimmune response by revealing
immunocryptic fragments in a proimmune apoptotic setting. Study of the immunogenicity of
these fragments may yield insights into the autoimmune targeting ofmolecules. Moreover, the
autoantibodies described will be valuable tools for the elucidation of mechanistically important
proteolytic steps along the apoptotic pathway.
T
he importance of specific proteolysis in mediating the
apoptotic process has been underscored in genetic anal-
ysis of apoptosis in Caenorhabditis elegans, where the ced-3
gene is required for execution of apoptosis (1) . The protein
encoded by ced-3 is homologous to the IL-1p-converting
enzyme (ICE)' family of cysteine proteases (2), especially in
the substrate-binding and catalytic domains (3-5). This
protease family is rapidly expanding and now includes at
least three additional members (Nedd2/Ich-1 [6, 7], CPP32/
prICE [8, 9], and TX [10]). All cloned members of this
family have been shown to induce apoptosis when overex-
pressed in different cell types (6-8, 10, 11). It has recently
been demonstrated that the active form of CPP32 is the
enzyme responsible for the specific proteolytic cleavage of
poly(ADP-ribose) polymerase (PARP) that occurs at the
onset of apoptosis (12) . Furthermore, specific inhibition of
CPP32 activity attenuates apoptosis in vitro, strongly sug-
gesting that proteolytic activity of this enzyme is mechanis-
tically important in the apoptotic process (12) . The obser-
vation that overexpression of crmA (a protease inhibitor of
the serpin family that potently inhibits ICE) abolishes the
ability of some ICE family members to induce apoptosis
further supports the proposal that proteolysis of key sub-
strates by ICE-like proteases mediates apoptosis (13). The
'Abbreviations used in this paper: DNA-PK, DNA-dependent protein ki-
nase; IAA, iodoacetamide; ICE, IL-1(3-converting enzyme; PARP,poly-
(ADP-ribose) polymerase; TLCK, tosyl-L-lysine chloromethylketone.
identification of key substrates whose cleavage might medi-
ate apoptosis therefore constitutes a major challenge. It is
intriguing that the only two proteins demonstrated to date
to be proteolytically cleaved by ICE-like enzymes during
apoptosis (PARP and U1-70kDa) are both nuclear autoan-
tigens (9, 14) .
We have previously demonstrated that the autoantigens
targeted in SLE are clustered in two discrete populations of
surface structure on apoptotic cells: (a) apoptotic bodies
that arise from the condensed, fragmented nucleus, and (b)
numerous small surface blebs that arise from fragmented
rough endoplasmic reticulum (ER) (15) . We proposed that
this "clustered targeting" of unique autoantigens by the im-
mune system might reflect the susceptibility ofthese partic-
ular molecules to common biochemical modifications in
these apoptotic microenvironments (15) .
Only a minor fraction of all potential antigenic determi-
nants on a molecule are presented on MHC class II mole-
cules during natural processing of whole protein antigens
(16). This immunodominance of a peptide appears to be
determined by its intrinsic affinity for MHC class II, as well
as by flanking regions that may influence its interactions
with the binding groove (16) . Several studies have suggested
that self-tolerance is only induced to efficiently presented,
dominant determinants, but not to cryptic determinants on
self-molecules (17-19). Thus, potentially autoreactive T
cells that recognize the cryptic regions ofself-molecules still
exist for many antigens (20-22) . Furthermore, immuniza-
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area of the self-molecule (17, 22). If the whole autoantigen
is also present, this autoreactive T cell response may subse-
quently diversify to other areas on the self-molecule to which
the organism was previously tolerant (21, 22). Since limited
proteolysis might reveal cryptic epitopes, it is possible that
activation of apoptosis-specific proteases in apoptotic surface
blebs may define the specific protease substrates at these sites
as autoantigens.
In these studies, we have shown that a subset of infre-
quently targeted autoantigens is united by theirspecific pro-
teolytic cleavage early during apoptosis. The kinetics and in-
hibition characteristics of these cleavages are identical and
implicate an ICE-like protease(s). Further study of these
apoptosis-specific proteolytic cleavages will yield new in-
sights into the biochemical mechanisms underlying this cell
death process. Furthermore, studies of the immunogenicity
of the relevant fragments may provide a powerful system
with which to explore the autoimmune targeting ofself.
Materials and Methods
Cell Culture and Induction ofApoptosis.
￿
HeLa cells were passaged
in 10% heat-inactivated calf serum using standard tissue culture
procedures. Apoptosis was induced by irradiation with UVB us-
ing the conditions previously described (15) . Briefly, confluent
HeLa monolayers were washed twice with PBS (2.7 mM KCI,
1.5 mM KH2PO4, 137 mM NaCl, and 8 mM Na2HPO4) and ir-
radiated in PBSwith 1,650J/m2 UVB. The cells were then incu-
bated in growth medium in a 7.5% C02-humidified incubator
for0, 3, 6, or 9 h as indicated in thefigure legends. At each ofthese
times except 0 h after UVB irradiation, apoptotic cells were readily
detectable morphologically; mixed populations of adherent cells
(early apoptosis), floating blebbed cells (established apoptosis), and
dispersed fragments (late apoptosis) were observed (14). Cell death
by apoptosis was confirmed by visualization of intemucleosomal
DNA cleavage on agarose gels (data not shown).
Apoptotic Lysates.
￿
Apoptoticlysates, consisting ofthe combined
adherent and floating populations, were prepared at the appropri-
ate times after UVB irradiation as follows. Culture dishes were
chilledto 4°C, and the medium was separated from adherent cells
by gentle aspiration of the former. The adherent cells were washed
twice with PBS, and then lysed in buffer A (1% NP-40, 20 mM
Tris, pH 7.4, 150 mM NaCl, and 1 mM EDTA containing the
following protease inhibitors: pepstatin A, leupeptin, antipain,
chymostatin, and PMSF). The aspirated medium was centrifuged
at 16,000 g, and the resulting pellets were washed once with
PBS before adding to the lysates of their adherent counterparts.
Control, unirradiated HeLa cultures were processed similarly,
except that the medium was discarded because it contained no
floating cellular material (thatis, these lysates consisted only ofad-
herent cells). Protein assays were performed on all lysates (Bio-
Rad Laboratories, Richmond, CA) with gamma-globulin as a
standard.
Proteins and Protease Inhibitors.
￿
Purified DNA-dependent pro-
tein kinase (DNA-PK) was obtained from Promega (Madison, WI).
Protease inhibitor stock solutions were made up in distilled deion-
ized water as follows: 20 MM tosyl-t-lysine chloromethyl ketone
(TLCK, Boehringer Mannheim Corp., Indianapolis, IN); 10 mM
iodoacetarnide (IAA; Sigma Chemical Co., St. Louis, MO).
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Gel Electrophoresis andImmunoblotting.
￿
Electrophoresis was per-
formed on 10% SDS-polyacrylamide gels containing 0.087% his-
acrylamide. Proteins were subsequently transferred to nitrocellu-
lose (23), and immunoblotting was performed using enhanced
chemiluminescence accordingto themanufacturers' directions (Am-
ersham Corp., Arlington Heights, IL). Scanning ofautoradiograms
was performed on ascanner (Scarnnaker IIXE; Microtek, Redondo
Beach, CA) before quantitation (Sigmascan/Image software;Jan-
del Scientific, San Rafael, CA). All autoradiographic bands scanned
were within the linear range of the x-rayfilm.
Antibodies andAntibody Screening Procedures.
￿
Reactivity of hu-
man autoimmune sera with saline soluble extracts ofhuman spleen
and rabbit thymus was determined by Ouchterlony double im-
munodiffusion using standard reference sera to Jo-1, Ro, La, Sin,
U1-70kDa, andScl-70 (topoisomerase 1) (24). 260precipitin-pos-
itive sera, including those against unidentified antigens, were fur-
ther screened by immunoblotting against HeLa lysates, using the
primary antibodies at a minimum dilution of 1:5,000. Only sera
that gave strong autoradiographic bands (i.e., bands that were readily
detected with enhanced chemiluminescence after <15 s exposure
of the x-ray film) were further evaluated. Sera from healthy con-
trols did not inuaunoblot any proteins using identical screening
conditions (data not shown). The following reference sera were
also used in invnunoblotting experiments : PARP, fibrillarin, to-
poisomerase II, calreticulin, ribosomal protein P, andp70/p80 Ku.
Amity Purification of Antibodies from Human Sera.
￿
HeLa cells
were lysed in buffer A containing protease inhibitors, subjected
to electrophoresis on preparative gels, and transferred to Immo-
bilon (Millipore Corp ., Bedford, MA). The immobilized proteins
were used to affinity purify antibodies from RW and AG sera as
described (15) .
Immunofuorescence Microscopy.
￿
Immunofluorescence microscopy
was performed on HeLa cells grown on No. 1 glass coverslips. Cells
were fixed in 4% paraformaldehyde (5 min, 4°C) before perme-
abilization in acetone (30 s, 4°C) and staining with the standard
monospecific serum recognizing PART (diluted 1:160 in PBS)
(25). Bound antibodies were visualized with fluorescein-conju-
gated goat anti-human F(ab')2 (Organon Teknika Corp./Cappel,
Durham, NC). After washing in PBS, cells were counterstained
with propidium iodide (5 jig/nil in PBS; Molecular Probes, Inc.,
Eugene, OR) for 30 s. Coverslips were mounted on glass slides
with Permafluor (Lipshaw, Pittsburgh, PA) and viewed on ascan-
ning confocal microscope system (model MRC600; Bio-Rad
Laboratories).
Results
Several Different Autoantigens Are Specifically Cleaved during
Apoptosis. Two autoantigens (Ul-70kDa and PARP) have
previously been shown to be cleaved by proteases with ICE-
like features in the apoptotic setting, generating fragments
of 40 and 85 kD, respectively (Fig. 1, lanes 1-4) (9, 14) . To
address whetherother autoantigens might be similarly cleaved
during apoptosis, 260 sera containing high titers ofautoan-
tibodies were screened by immunoblotting against lysates
of apoptotic and control HeLa cells. Several autoimmune
sera were identified that recognized proteins that were spe-
cifically cleaved during apoptosis (Fig. 1) . Sera HM andJE
recognized 170- and 75-kD proteins, respectively, which
gave rise to fragments of 155 and 60 kD in apoptotic cells
(Fig. 1, lanes 5-8) . Serum RW immunoblotted three prom-Figure 1 . Several different autoantigens are
cleaved during apoptosis . HeLa cells were in-
duced to become apoptotic by irradiation with
UVB followed by incubation at 37°C for 9 h
(lanes 2, 4, 6, 8, and 10) or 6 h (lane 12) . These
cells, as well as control unirradiated HeLa cultures
(lanes 1, 3, 5, 7, 9, and 11), were then lysed and
immunoblotted with antisera from the following
patients: HM (lanes 5 and 6), JE (lanes 7 and 8),
RW (lanes 9 and 10), AG (lanes 11 and 12), or
standard sera for UI-70kDa (lanes 1 and 2) and
PARP (lanes 3 and 4) . Note that for greater clar-
ity ofpresentation ofthe complex blotting profile
of AG, the 6 h after irradiation time was used
(lane 12) . This demonstrates both intact and frag-
mented forms of the different antigens simulta
neously, whereas the former are barely detectable in theAG profile seen at 9 h (compare Fig. 3, lanes 5 and 6, 9 and 10) . Equal amounts ofprotein were
loaded in both lanes of each pair, but varied between pairs (70-85 la,g protein/lane) as did autoradiogram exposure times (2-15 s) . Identical results were
obtained in six to nine separate experiments performed with each serum . Migration positions ofmolecular weight standards are marked down the left side
ofeach set .
inent proteins of 195, 112, and 50 kD (Jo-1) (Fig. 1, lane
9) . In apoptotic cells, the chemical amounts of the 195-
and 112-kD proteins were decreased, and two new, dis-
crete fragments of 160 and 35 kD were generated ; in con-
trast, levels ofJo-1 remained constant (Fig . 1, lane 10) . The
appearance ofa large amount ofthe 160-kD protein in apop-
totic cells could not be accounted for by a proportional de-
crease in the levels of the 195-kD protein, from which the
160-kD protein was presumed to arise . Furthermore, the
source ofthe 35-kD fragment was not clear . To unequivo-
cally determine the origin of these two apoptotic frag-
ments, we affinity purified three antibodies from serum
RW that recognized the 195-, 112-, and 50-kD antigens in
control HeLa lysates . Antibodies purified against the 195-
kD protein recognized both the 160- and 35-kD fragments
in apoptotic cells (Fig. 2, lanes 3 and 4) . No fragments were
recognized in apopotic cells by antibodies affinity purified
against the 112- or 50-kD antigens, although the chemical
amount of the 112-kD protein was clearly decreased (Fig.
2, lanes 5-8) . Antibodies affinity purified against the 160-
kD protein from apoptotic cells recognized only the 160-
and 195-kD forms of the protein, and failed to recognize
the 35-kD fragment (data not shown) . These data confirmed
that, although the 160- and the 35-kD fragments are both
derived from the intact 195-kD protein, they are recog-
nized by distinct antibodies . Since the sizes of these two
fragments together account for the entire 195-kD protein,
it is likely that they are contiguous and arise from a single
proteolytic cleavage .
In contrast to the five sera presented above in which only
one of the proteins recognized by a particular autoimmune
serum was cleaved in apoptotic cells, an extremely interest-
ing serum (AG) was identified that recognized multiple
proteins that were cleaved during apoptosis. This serum was
derived from a patient with SLE and myositis, who also had
high-titer antibodies to double-stranded DNA . In control
HeLa lysates, this serum recognized five proteins ofthe fol-
lowing molecular masses : 350, 190, 140, 130, and 110 kD
(Fig . 1, lane 11) . A protein of 195 kD was also intermit-
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tently recognized in some lysates ofHeLa cells (Fig. 1, lane
11) . When serum AG was immunoblotted against lysates of
apoptotic HeLa cells, the chemical amounts of four of these
proteins (350, 190, 130, and 110 kD) were decreased com-
pared with controls, whereas the amount ofthe 140-kD pro-
Figure 2 . The 195-kD autoantigen recognized by RW undergoes a
single cleavage in apoptotic cells to generate fragments of 160 and 35 kD.
HeLa cells were induced to become apoptotic by irradiation with UVB
followed by incubation at 37°C for 9 h (lanes 2, 4, 6, and 8) . These cells,
as well as control unirradiated cultures (lanes 1, 3, 5, and 7), were then
immunoblotted with RW serum (lanes 1 and 2) or IgG affinity purified
against the three antigens recognized by serum RW : A, IgG affinity puri-
fied against the 195-kD antigen (lanes 3 and 4) ; B, IgG affinity purified
against the 112-kD antigen (lanes 5 and 6) ; and C, IgG affinity purified
against the 50-kD Jo-1 antigen (lanes 7 and 8) . 115 Etg of protein was
subjected to electrophoresis in each gel lane . Migration positions ofmo-
lecular weight standards are marked between lanes 2 and 3 . The band mi-
grating at 63 kD in lanes 3 and 4 is nonspecific and was detected in the
other lanes at longer exposure times (data not shown) .tein remained unchanged . In addition, three new discrete
immmunoreactive fragments o£ 150, 118, and 85 kD were
detected by serum AG in apoptotic lysates (Fig. 1, lanes 11
and 12) . To identify from which antigens these new frag-
ments were derived, antibodies to each of the antigens rec-
ognized in control HeLa lysates were affinity purified and
then used to blot apoptotic lysates . These studies demon-
strated that the 150-kD fragment arose from the 350-kD
antigen (Fig . 3, lanes 3 and 4), the 118-kD fragment arose
from the 130-kD antigen (Fig. 3, lanes 7 and 8), and the
85-kD fragment arose from the 110-kD antigen (Fig . 3,
lanes 9 and 10) . Although no autoantigens of350 kD have
previously been described, the 350-kD catalytic subunit of
the DNA-PK forms a complex with its regulatory compo-
nents, the p70/p86 Ku proteins, which are well-described
autoantigens in human autoimmune disease (26-28) . To
confirm whether the 350-kD autoantigen was indeed the
catalytic subunit ofDNA-PK, purified HeLa cell DNA-PK
was electrophoresed adjacent to lysates from control and ap-
optotic HeLa cells, before immunoblotting with antibodies
affinity purified against purified DNA-PK, as well as an
mAb against p350 . Both these antibodies recognized the
purified 350-kD protein and the comigrating protein in
HeLa lysates (Fig. 4, lanes 1 and 2 and data not shown) .
Furthermore, the affinity-purified human antibodies recog-
nized the 150-kD fragment in apoptotic lysates (Fig. 4, lane
3), whereas the mAb recognized the complementary 220-kD
Figure 3 .
￿
Three different autoantigens detected by patient serum AG
are proteolytically cleaved in apoptosis . HeLa cells were induced to be-
come apoptotic by irradiation with UVB followed by incubation at 37 °C
for 9 h (lanes 4, 6, 8, and 10) or 6 h (lane 2) . Lysates prepared from these
cells, as well as control unirradiated cultures (lanes 1, 3, 5, 7, and 9), were
immunoblotted with AG serum (lanes 1 and 2) or were IgG affinity puri-
fied against the following antigens recognized by AG serum: A, 350 kD
(lanes 3 and 4) ; B, 190 kD (lanes 5 and 6) ; C, 130 kD (lanes 7 and 8) ; and
D, 110 kD (lanes 9 and 10) . For greater clarity ofpresentation, the 6 h af-
ter irradiation time was used to show the AG serum blotting profile (lane
2), since this demonstrates both intact and fragmented forms ofthe differ-
ent antigens simultaneously . The solid dots adjacent to A, B, C, and D
denote new fragments detected in apoptotic lysates . 120 Wg of protein
was loaded in each lane . Migration positions of molecular weight stan-
dards are indicated on the left side ofA-D . nls, nonspecific .
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Figure 4 .
￿
The 350-kD antigen recog-
nized by serum AG is the catalytic sub-
unit ofDNA-PK . HeLa cells were in-
duced to become apoptotic by
irradiation with UVB, followed by in-
cubation at 37°C for 9 h . Lysates from
these cells (lane 2) as well as those ob-
tained from control, unirradiated cul-
tures (lane 1) were subjected to electro-
phoresis adjacent to DNA-PK purified
from HeLa cells (lane 3) . The samples
were immunoblotted with IgG affinity
purified against DNA-PK (AG serum
was used for the affinity purification) .
115 jig ofprotein was subjected to elec-
trophoresis in lanes 1 and 2, and 0 .7 lag
in lane 3 . The upper and lower bands
migrate at 350 and 150 kD, respectively .
The experiment was performed on three
separate occasions, with identical results.
fragment of p350 (data not shown) . The 350-kD autoanti-
gen is therefore the catalytic subunit of DNA-PK . These
studies provide the first direct evidence that p350 DNA-PK
(a) is an infrequently targeted autoantigen in autoimmune
disease, and (b) is proteolytically cleaved during apoptosis . It
is of note that serum AG did not recognize the p70/p86
Ku proteins by immunoblotting, nor did it coprecipitate
this heterodimer from metabolically labeled HeLa cells
lysed in a buffer containing 1% NP-40 (data not shown) .
Using reference sera to the Ku proteins, we established by
immunoblotting that the p70/p86 proteins remained intact
in apoptotic HeLa cell lysates (data not shown) . These data
are in partial contrast to a recent study that demonstrated
decreased levels ofboth p350 and the Ku subunits in apop-
totic PBLs and HL60 cells (29) . That study is not directly
comparable to the data reported here, because it did not
address changes in Ku levels early after delivery of a syn-
chronized proapoptotic stimulus, as was done here (see ki-
netics below) .
The 110-kD protein recognized by serum AG was posi-
tively identified as PARP by the following criteria : (a) An
85-kD fragment was generated in apoptotic cells (9) ; (b) both
the intact protein and the fragment comigrated on SDS-
PAGE with proteins recognized by standard anti-PARP sera
(data not shown) ; and (c) when control HeLa lysates were
immunoprecipitated with standard antibodies to PARP,
followed by immunoblotting with serum AG, the 110-kD
PARP protein was specifically recognized (data not shown) .
We confirmed that the fragments detected by the six dif-
ferent sera shown in Fig . 1 were not unique to HeLa cell
apoptosis by examining lysates made from apoptotic humankeratinocytes, human umbilical vein endothelial cells, and a
mouse pre--B cell line (103 cells) . Identical apoptotic frag-
ments were observed in all these cell types, except that p350
and its fragment were absent from the murine cell line, a
finding consistent with previous observations (30 and data
not shown) . Generation of the various fragments was spe-
cific to apoptosis since similar fragments were never ob-
served if necrosis was induced by heat shock or incubation
in high concentrations ofH202 (data not shown) .
With the exception of U1-70kDa (to which high-titer
antibodies were found in -10% of screened sera), the au-
toantigens described in Fig . 1 were the infrequent target of
a high-titer autoantibody response, found in <1% of sera
screened. No other frequently targeted autoantigen in SLE,
scleroderma, or polymyositis (including 52- and 60-kD Ro,
ribosomal protein P, Sm, calreticulin, p70/p80 Ku, topo-
isomerase I, fibrillarin, and Jo-1) was cleaved during apop-
tosis (data not shown) .
Kinetics ofAutoantigen Cleavage during Apoptosis .
￿
The acti-
vation of ICE-like enzymes in cells undergoing apoptosis is
a necessary step in the apoptotic process (12) . Since mecha-
nistically important proteolytic cleavages are likely to occur
before or coincident with the onset ofapoptotic morphol-
ogy, we examined the kinetics of autoantigen cleavage in
HeLa cells after UVB irradiation to address directly whether
there was any correlation between these events . We found
that the 150-kD DNA-PK fragment was clearly seen 3 h
after irradiation (Fig . 5, top panel), coincident with the on-
set of detectable apoptotic morphology (data not shown) .
As incubation times after irradiation increased, the chemi-
cal amounts of intact p350 decreased, accompanied by a
concomitant stoichiometric increase in the amount of the
150-kD fragment . The kinetics of cleavage of all the pro-
teins shown in Fig . 1 were identical to each other and to
p350 ; PARP, as well as sera JE and HM, is shown as a rep-
resentative example (Fig . 5) . In all instances, >50% of the
intact antigen was cleaved into the fragment by 9 h after ir-
radiation (Fig . 5) .
Interestingly, we noted that La and topoisomerase I, two
autoantigens previously found to be sensitive to proteolysis
during purification (31, 32), were also cleaved in apoptotic
cell populations . In contrast to the kinetics of the cleavages
described above, the La and topoisomerase I cleavages only
occurred several hours after the morphologic onset of apop-
tosis, and <10% of the total autoantigen was cleaved at 9 h
(Fig. 5 and data not shown) . Cleavage ofthe intact 100-kD
topoisomerase I generated a 70-kD fragment (Fig. 5, lowest
panel), whereas proteolysis of the intact 48-kD La molecule
generated a 43-kD fragment as previously described (33
and data not shown) . Furthermore, in contrast to the cleav-
ages shown in Fig . 1, those of La and topoisomerase I had
acidic pH optima and occurred even in lysates of nonapop-
totic cells incubated in vitro (data not shown) .
Inhibition Characteristics ofAutoantigen Cleavage in Apoptotic
Cells . Since the cleavage kinetics ofthe autoantigens shown
in Fig . 1 were all identical to that ofPARP, and since prICE/
CPP-32 generates this specific PARP cleavage in apoptotic
cells, we studied the inhibition characteristics of the activ-
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Figure 5 .
￿
Kinetics of apoptotic fragment generation . HeLa cells were
induced to become apoptotic by irradiation with UVB and were then in-
cubated at 37°C for 0 (lane 2), 3 (lane 3), 6 (lane 4), or 9 h (lane 3) . Con-
trol cultures (lane 1) were not irradiated with LJVB . At the indicated
times, cultures were lysed . Equal protein aliquots (110 NLg) were subjected
to electrophoresis and immunoblotted with the following sera : p350 (top
panel), PARP (secondpanes, JE (third panel), HM (fourth panel), and topo-
isomerase I (lowestpanes . Migration positions ofthe intact protein and any
fragment(s) generated are marked and were as follows : p350, 350 (intact)
and 150 kD (fragment) ; PARP, 110 (intact) and 85 kD (fragment) ; JE, 75
(intact) and 60 and 57 kD (fragments) ; HM, 170 (intact) and 155 kD
(fragment) ; and topoisomerase I, 100 (intact) and 70 kD (fragment) . Iden-
tical results were obtained in two separate experiments with each serum .
ity(ies) responsible for these cleavages in apoptotic cells.
HeLa cells were irradiated to induce apoptosis and then in-
cubated in the absence or presence of various protease in-
hibitors, added individually . Leupeptin, antipain, pepstatin A,
chymostatin, PMSF, E-64, and acetyl-leucyl-leucyl-norme-
thional did not prevent cleavage of these autoantgens, nor
did they alter the morphology of apoptosis as assessed by
phase contrast microscopy (12 and data not shown) . Frag-
mentation of PARP was entirely prevented by incubation
of irradiated cells with 50 p,M IAA (Fig. 6, top panel, lane 2)
or 1 mM TLCK (Fig . 6, top panel, lane 3) . Similar findings
were made for sera recognizingJE and U1-70kDa (Fig. 6),
as well as HM, RW, and AG (data not shown) . Addition of
100 wM of the specific tetrapeptide ICE inhibitor N-(N-
Ac-tyr-val-ala)-3-amino-4-oxobutanoic acid to the incuba-
tion medium resulted in only minimal inhibition ofautoan-
tigen cleavage (10-30% in different experiments) (data not
shown) . Furthermore, purified recombinant human ICE was
unable to cleave these substrates in vitro when added to cell
lysates (14 and data not shown), reinforcing that apoptotic
ICE homologues, rather than ICE itself, might be responsi-
ble for the cleavage ofthese proteins in apoptosis (9, 12, 14,
34, 35) . Since the substrate specificity of the two ICE ho-Figure 6 .
￿
Effect ofprotease inhibitors
in vivo on apoptotic fragment genera-
tion . HeLa cells were irradiated with
UVB and then incubated for 3 h in
growth medium containing the follow-
ing protease inhibitors : no inhibitors
(lane 1), 50 IiM IAA (lane 2), or 1 mM
TLCK (lane 3) . The cells were then ly-
sed and immunoblotted with standard
sera against PARP (top panel), Ul-
70kDa (lowest panel), or patient serumJE
(middle panel) . 120 N,g of protein was
subjected to electrophoresis in each lane .
Migration positions ofthe intact protein
and the fragment were as follows:
PARP, 110 (intact) and 85 kD (frag-
ment) ; JE, 75 (intact) and 60 kD (frag-
ment) (note that no 57-kD fragment is
detected 3 h after irradiation; see Fig . 4) ;
and Ul-70kDa, 67 (intact) and 40 kD
(fragment) . Identical results were ob-
tained in two separate experiments with
each serum .
mologues described to date are different, these proteases are
thus most effectively inhibited by different tetrapeptide al-
dehydes (12) . Specific inhibitor studies on the substrates
identified here must therefore await the sequencing of in-
tact autoantigens and identification of their cleavage sites .
Interestingly, degradation of the 190- and 112-kD pro-
teins recognized by sera AG and RW, respectively, which
produce no detectable fragments in apoptotic cells, was not
prevented by IAA or TLCK (data not shown) . Since these
cleavages occur early during apoptosis but do not share the
inhibition characteristics of the other antigens described, it
is likely that they are substrates for another family of pro-
teases active during apoptosis . Indeed, activity ofother pro-
tease families (e.g., calpain) during apoptosis has recently
been suggested (36) .
NuclearAutoantigens Are Redistributed during Apoptosis .
￿
Al-
though the ICE-like proteases purified to date have all
been isolated from the cytosol, PARP is nuclear in distri-
bution (25) . Interestingly, U1-70kDa and p350 DNA-PK
are also nuclear proteins, as is the unidentified 75-kD anti-
gen recognized by serum JE . We have previously demon-
strated that U1-70kDa is redistributed in apoptotic cells,
appearing first as a rim around the condensing chromatin
and subsequently around apoptotic bodies at the cell sur-
face as the nucleus fragments (15) . A similar morphologic
sequence was demonstrated for PARP in apoptotic cells
(Fig . 7), using a human serum that was monospecific by
immunoblotting and immunoprecipitation (25 and Fig . 1,
lane 3) . PARP stained exclusively in the nucleus of HeLa
cells before irradiation, with a homogeneous pattern that ex-
cluded nucleoli (Fig . 7 A) . At all stages of apoptosis, PARP
staining was associated only with the condensed nucleus or
its fragments and was never detected in the cytosol (Fig . 7,
B--D) . These results were confirmed biochemically by im-
munoblotting NP-40 HeLa lysates that were separated into
nuclear pellet and postnuclear supernatant (>90% of both
1630
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PARP and its fragment were present in the nuclear pellet ;
data not shown) .
Discussion
A Subset of Infrequently Targeted Autoantigens Is Cleaved
Early during Apoptosis . These studies have defined a group
ofautoantigens that is specifically cleaved early during apop-
tosis . Members of this group include the 350-kD catalytic
subunit of DNA-PK, PARP, and U1-70kDa, as well as
unidentified autoantigens of 195, 170, 130, and 75 kD . All
seven cleavages generate discrete fragments that are not fur-
ther processed . In all cases, >50% of the total protein is de-
graded to the fragment in apoptotic cells . Affinity-purified
antibodies recognize both the intact and cleaved forms of
the molecules . The cleavages are observed when apoptosis
is induced in multiple different cell types and are never de-
tected after lysis ofnonapoptotic control cells, or in cells ren-
dered necrotic by a variety ofinsults . These early, apoptosis-
specific cleavages may be ofpotential mechanistic significance
in this cell death process . They are to be contrasted with the
cleavage of topoisomerase I and La, which is minimal, late,
and not specific to apoptotic cells.
Kinetics and Inhibition Characteristics of Cleavage Indicate the
Involvement ofan ICE-like Protease(s) . The formation ofsuch
discrete protein fragments in apoptotic cells and their lack
of further processing strongly suggest (a) the presence of
highly restricted cutting sites in the cleaved proteins, and
(b) the activity of a limited number of proteases in this set-
ting. Furthermore, the inhibition characteristics of all the
cleavages described in Fig. 1 are quite striking; like PARP,
they are completely inhibited by IAA and TLCK treatment
of intact cells (37), but not by other inhibitors of serine and
cysteine proteases, including leupeptin, PMSF, chymosta-
tin, antipain, acetyl-leucyl-leucyl-normethional, and E-64 .
These mixed inhibition characteristics are identical to those
observed forPARP cleavage (37), which is catalyzed by the
apoptotic ICE homologue, CPP32 (12) . They strongly sug-
gest the involvement of member(s) of the ICE family, ei-
ther directly (as for PARP), or perhaps upstream of these
cleavages in an apoptotic protease cascade. Sequencing stud-
ies to determine the specific cutting site for each autoantigen
will be essential to resolve these possibilities, since ICE fam-
ily-mediated cleavages are absolute in their requirement of
an Asp in the P1 position (38) .
ICE-like Enzymes and Apoptosis.
￿
A growing number of
genes that have similarity to the ICE family of cysteine pro-
teases have recently been identified by sequence homology
studies (3, 6, 7, 10) . The respective substrates for these po-
tential proteases, however, are not yet known (3, 6, 7, 10) .
Since the proteolytic activity o£ the ICE family members
studied to date appears to be highly restricted (ICE cleaves
only pro-IL-1 R, and not PARP, and CPP32 cleaves PARP
and not pro-IL-1 (3 [9, 12]), it is likely that these other ICE
family members will be active against a limited group of
substrates . We propose that the infrequently targeted au-
toantigens described here are some of the possible substratesFigure 7 .
￿
PARP stains the rim ofthe condensing apoptotic nucleus and is found in apoptotic bodies at the cell surface. Unirradiated (A) and irradiated
(B-D) HeLa cells were double stained with a monospecific human PARP standard serum and with propidium iodide, and were examined by confocal
fluorescence microscopy . PARP antibodies were visualized with FITC-goat anti-human antibodies and assigned the color green, whereas propidium io-
dide staining was assigned as red . In unirradiated cells (A), PARP stained diffusely throughout the nucleus, excluding nucleoli . In apoptotic cells (B-D),
propidium iodide staining of small surface blebs and apoptotic bodies was prominent . PARP staining was condensed in the nucleus ofearly apoptotic cells
(B and G) and surrounded apoptotic bodies after nuclear fragmentation (D) . No staining in the FITC channel was seen ifprimary antibody was omitted.
Duplicate coverslips were prepared, and at least 50 apoptotic cells per coverslip were examined ; representative cells are presented. The experiment was re-
peated on three separate occasions, with similar results . Bars, 5 Rm .
for these proteases, and the autoantibodies that recognize
the intact proteins and their fragments will provide the
tools to further elucidate the roles ofthe ICE family ofpro-
teases during apoptosis .
Although it is still uncertain how cleavage ofspecific mol-
ecules might mediate the apoptotic process, it is of great in-
terest that two of the cleaved proteins, PARP and DNA-
PK, have roles in DNA break repair (39-42) . The specific
cleavage of these two enzymes is tantalizing, since a hall-
mark biochemical feature of apoptosis is the generation of
large numbers of internucleosomal DNA breaks . These
breaks are a potent stimulus for activation ofDNA repair
systems . The cleavage ofPARP and DNA-PK is therefore
physiologically consistent in apoptosis (to terminate DNA
repair in a cell that has already become committed to die),
but it remains unclear whether cleavage of these substrates
is mechanistically critical for the apoptotic pathway . It will
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therefore be important to determine the effects ofproteoly-
sis on the function ofthese enzymes in their respective path-
ways . Furthermore, elucidating the identities of the other au-
toantigens described in this study and their cellular functions
might yield new insights into the mechanisms and control
ofthis important form of cell death .
Although both ICE family members purified to date
have been derived from cytosolic extracts (2, 12), PARP is
found exclusively in the nucleus (Fig. 7 ; 25) . Furthermore,
two other proteins described in this paper (U1-70kDa and
p350 DNA-PK) whose cleavage kinetics and inhibition
characteristics are identical to those ofPARP are also cata-
lytic nuclear proteins . These three proteins are immuno-
stained in apoptotic bodies, as are the autoantigens recog-
nized by serumHM and JE (15 and data not shown) . Even
late in apoptosis, PARP remains associated with the nu-
cleus and its fragments and is never found in the cytoplasm .This predicts that the responsible ICE family members or
downstream proteases have access to the nucleus or its frag-
ments in apoptotic cells.
Novel Fragmentation of Autoantigens and Immunogenicity.
It has been proposed that some autoreactive T cells escape
tolerance induction because they are directed against cryptic
determinants on self-antigens that are not efficiently gener-
ated during antigen processing (for review see reference 16).
These autoreactive cells may become pathogenic if that
cryptic determinant is subsequently revealed. It is possible
that the generation of novel protein fragments by apopto-
sis-specific proteases might be a mechanism to reveal this cryp-
tic structure. In all the sera presented here, the proteolytic
fragments in apoptotic cells are recognized by the autoanti-
body response, an observation that is consistent with this
mechanism. The enhanced recognition by the autoantibody
response ofproteolytic fragments ofcertain autoantigens in
apoptotic cells (e.g., as is seen with the 160-kD RW frag-
ment) further supports this hypothesis.
Serum AG is of great significance because three of the
five proteins targeted by this patient serum were cleaved
during apoptosis. The kinetics and inhibition features of all
cleavages were identical. The limited proteolysis of three
infrequently targeted autoantigens in a single patient argues
persuasively for the important role of cleavage in defining
these molecules as autoantigens. Further study of the im-
munogenicity of these autoantigen fragments in in vitro
and in vivo models will be essential to test this hypothesis.
Although thymocyte apoptosis during positive and nega-
tive selection has recently been persuasively demonstrated
in situ by demonstrating DNA strand breaks (43), it is not
yet clearwhether the other biochemical mechanisms ofthy-
mic apoptosis and clearance of apoptotic material are iden-
tical to those found at peripheral sites. It will be essential to
evaluate whether these specific autoantigen cleavages occur
during the apoptosis of thymocyte selection, since the fail-
ure to generate these fragments in the thymus might deprive
the organism of necessary toleragens and allow the persis-
tence of potentially autoreactive T cells.
ModelofAutoimmunity.
￿
We have previously demonstrated
that apoptosis induces the physical clustering ofautoantigens
in two distinct populations of cell surface structures (15).
We proposed that this clustered targeting of autoantigens
by the immune system might reflect the susceptibility of
these molecules to a common biochemical modification in
this apoptotic microenvironment (15) . In these studies, we
have shown that a distinct subset of infrequently targeted
autoantigens is united by their specific proteolytic cleavage
early during apoptosis. We therefore propose that cleavage
of these autoantigens targets them for an autoimmune re-
sponse, perhaps by revealing previously immunocryptic
fragments. This will only occur in individuals who possess
class II MHC molecules that can bind to and present these
cryptic determinants to potentially autoreactive T cells (16) .
The lack of proteolytic cleavage of the ribonucleoprotein
and deoxyribonucleoprotein autoantigen complexes more
frequently targeted in individuals with autoimmune diseases
suggests that other biochemical mechanisms (e.g., nuclease
activity, generation of reactive oxygen species) may be op-
erative in apoptotic cell surface blebs that render components
of these complexes immunogenic. Altered structure of clus-
tered autoantigen molecules, when occurring in novelproim-
mune contexts (e.g', viral infection [44]) or antigen-present-
ing microenvironments (e.g., Langerhans cell-rich epidermis),
may be the proximate mechanism underlying the autoim-
mune targeting ofself.
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